Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2005
03/08/2005US6864070 Polypeptide for use in the treatment of vision defects and psychological disorders
03/08/2005US6864062 Purified antigen for Alzheimer's disease and methods of obtaining and using same
03/08/2005US6864047 Culturing stromal cells with bone marrow, quantitative determining the concentration of interleukins by comparing to a standard curve; identifying a patient with a multiple myeloma- related plasmaproliferative disorder
03/08/2005US6863893 Vaccination of mammals with pneumococcal derived polypeptides that include an alpha helix but exclude a choline binding region as a mechanism for stimulating production of an antibody that protects vaccine recipient from infection
03/08/2005US6863890 Treatment of AIDS with antibodies to gamma interferon, alpha interferon and TNF-alpha
03/08/2005US6863888 Oncoprotein protein kinase
03/08/2005US6863887 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
03/08/2005CA1341474C Purified igm
03/03/2005WO2005019831A2 Methods for reducing complexity of a sample using small epitope antibodies
03/03/2005WO2005019827A1 Method of examining colon cancer and colon adenoma
03/03/2005WO2005019824A1 Methods for obtaining antibodies
03/03/2005WO2005019823A1 Methods for obtaining antibodies
03/03/2005WO2005019470A2 Detecting and profiling molecular complexes
03/03/2005WO2005019464A1 Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer
03/03/2005WO2005019463A1 Improved transgenesis with humanized immunoglobulin loci
03/03/2005WO2005019457A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
03/03/2005WO2005019432A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis
03/03/2005WO2005019431A2 Selective inhibition of toll-like receptor-2
03/03/2005WO2005019409A2 Combinatorial protein library screening by periplasmic expression
03/03/2005WO2005019407A2 Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases
03/03/2005WO2005019271A1 Anti-lewis y anti-idiotypic antibodies and uses thereof
03/03/2005WO2005019270A2 Endotheliase-2 ligands
03/03/2005WO2005019269A2 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
03/03/2005WO2005019268A1 Novel antibody against cancer antigen
03/03/2005WO2005019267A2 Tie1-binding ligands
03/03/2005WO2005019266A2 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
03/03/2005WO2005019259A2 Variants of interleukin-1 receptor antagonist: compositions and uses thereof
03/03/2005WO2005019248A1 Hiv immunogenic complexes
03/03/2005WO2005019243A1 Detecting molecules
03/03/2005WO2005018803A1 Immobilization matrix for peptides and proteins
03/03/2005WO2005018669A1 Fcϝriib-specific antibodies and methods of use thereof
03/03/2005WO2005018668A1 Method of inducing immune tolerance
03/03/2005WO2005018667A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
03/03/2005WO2005018666A1 Polypeptide multimers having antiviral activity
03/03/2005WO2005018665A1 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium spp
03/03/2005WO2005018575A2 Estrogen receptor modulators and uses thereof
03/03/2005WO2005018572A2 Improved antibodies having altered effector function and methods for making the same
03/03/2005WO2005018571A2 Compositions and methods for treating inflammatory lung disease
03/03/2005WO2005018554A2 Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
03/03/2005WO2005018538A2 Severe acute respiratory syndrome (sars) polypeptides, antibodies to sars polypeptides and the use thereof in diagnostic, vaccination and therapeutic applications
03/03/2005WO2005018536A2 Agonist antibodies that specifically bind the glucagon like peptide-1 receptor
03/03/2005WO2005018535A2 Compositions and methods for treatment of severe acute respiratory syndrome (sars)
03/03/2005WO2005018424A2 Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits
03/03/2005WO2005018413A2 Methods, kits and antibodies for detecting parathyroid hormone
03/03/2005WO2005000883A8 Polypeptides having binding affinity for insulin
03/03/2005WO2004113493A3 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
03/03/2005WO2004108764A3 Connective tissue growth factor antibodies
03/03/2005WO2004105793A3 Soluble clca-1 and antagonists to clca-1
03/03/2005WO2004101612A3 Thioredoxin-peroxidase of c. albicans as a virulence-specific marker
03/03/2005WO2004093893A3 Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques
03/03/2005WO2004092404A3 Inhibitors of acidic mammalian chitinase as asthma therapeutics
03/03/2005WO2004092353A3 Surface receptor complexes as biomarkers
03/03/2005WO2004075835A3 Methods for the treatment of renal cell carcinoma
03/03/2005WO2004072265A3 Methods for monitoring drug activities in vivo
03/03/2005WO2004071411A3 Methods and compositions in treating pain and painful disorders using 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620
03/03/2005WO2004069182A3 Active immunization to generate antibodies to soluble a-beta
03/03/2005WO2004059278A3 Methods of screening for anti-inflammatory drugs and use thereof
03/03/2005WO2004025256A3 Viral deconstruction through capsid assembly in vitro
03/03/2005WO2004019883A3 Tick polypeptides as anticoagulants and vaccines
03/03/2005WO2004012767A8 Medicinal agent and method for curing erectile dysfunction
03/03/2005WO2004012766A8 Method for correcting immune responses and medicinal agent
03/03/2005WO2003100006A3 Method of improved prostate cancer detection
03/03/2005WO2003048349A3 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
03/03/2005WO2003045317A3 Therapeutic protein and treatments
03/03/2005WO2003043566A3 Hip1 cancer markers
03/03/2005WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
03/03/2005US20050049403 Immunoglobulin for use in diagnosis, prevention and treatment of autoimmune, immunological and inflammatory disorders; immunotherapy
03/03/2005US20050049402 Antibodies directed to tumor necrosis factor and uses thereof
03/03/2005US20050049401 Immunoglobulin specific to fertility-associated antigen for use in monitoring reproductive status and diagnosing fertility disorders; animal husbandry and in vitro fertiization
03/03/2005US20050049218 Kidney or liver fibrosis; using antagonist against the mitogenic vascular endothelial growth factors (zvegf3), such as a monoclonal antibody against zvegf3, receptor binding variants, or antisense agents; antagonist of zvegf3 inhibits cell proliferation
03/03/2005US20050049185 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof
03/03/2005US20050049176 Treating a hypoproliferative cell disorder or disorder involving increased cell death in a patient by administering a therapeutically effective amount of an EphA2 antagonistic agent; treatment of Inflammatory Bowel Disease
03/03/2005US20050048645 Dendritic cells which present cryptococcus antigens for use in generating vaccines to prevent or treat microorganismal infection; immunotherapy; drug targeting and parasitic infection
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048628 Immunological binding molecules inhibiting the syncytial fusion of trophoblast
03/03/2005US20050048621 Using cytidine deaminase to generate variabilty in immunoglobulins; immunotherapy and directed protein evolution
03/03/2005US20050048617 Humanization of antibodies
03/03/2005US20050048607 Using activin receptor like kinases (ALK) as tool in identifying modulators for disganosis, prevention and treatment of cancer, rheumatoid arthritis and glomerulonephritis
03/03/2005US20050048606 Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist
03/03/2005US20050048589 Immunoglobulins for use in detecting, characterizing, preventing and treating human lung cancer; immunodiagnostics; immunotherapy
03/03/2005US20050048586 Using taste transduction G-protein coupled receptor polypeptides as diagnostic tools which identify modulators which enhance flavors and taste
03/03/2005US20050048578 Methods of screening for monoclonal antibodies with desirable activity
03/03/2005US20050048572 Immunoglobulin for use in treatment and prevention of immunological and cancer disorders; immunotherapy
03/03/2005US20050048566 Using high throughput assay to monitor differential protein expression in cells; bioinformatics and proteomics
03/03/2005US20050048565 Method of diagnosing or monitoring saccharometabolic error
03/03/2005US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides
03/03/2005US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy
03/03/2005US20050048520 Nogo receptor homologs
03/03/2005US20050048518 Laminin chains: diagnostic and therapeutic use
03/03/2005US20050048507 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/03/2005US20050048479 Adenylyl and guanylyl cyclases
03/03/2005US20050048478 Preparing agents which prevent and/or treat viral diseases; immunotherapy; mimetics
03/03/2005US20050048468 Immunoglobulin mixture for use as positive controls in multi-analyte immunoassays
03/03/2005US20050048133 Methods for treating ischemic disorders using carbon monoxide
03/03/2005US20050048070 Mixture of polypeptides from cytokeratins; anticancer agnets; vaccines
03/03/2005US20050048069 Methods and compositions for modulating immunity
03/03/2005US20050048068 Major histocompatibility complex epitopes; immunotherapy ; induce immunology response
03/03/2005US20050048065 Immunology response to antigen ; monoclonal antibodies
03/03/2005US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
03/03/2005US20050048063 Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 1494